Liu Y, Arora T, Zhang J, Sen B, et al. Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab. Osteoporos Int 2025 Sep 8. doi: 10.1007/s00198-025-07677.
PMID: 40920190